|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2100052100 |
|
最近更新日期: Date of Last Refreshed on: |
2021-10-17 22:45:34 |
|
注册时间: Date of Registration: |
2021-10-17 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
放散式体外冲击波治疗腰椎间盘突出症疗效观察 |
|
Public title: |
Observation on the Therapeutic Effect of Radial Extracorporeal Shock Wave in the Treatment of Lumbar Disc Herniation |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
放散式体外冲击波治疗腰椎间盘突出症疗效观察 |
|
Scientific title: |
Observation on the Therapeutic Effect of Radial Extracorporeal Shock Wave in the Treatment of Lumbar Disc Herniation |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
赵晨雪 |
研究负责人: |
马跃文 |
|
Applicant: |
Chenxue Zhao |
Study leader: |
Yuewen Ma |
|
申请注册联系人电话: Applicant telephone: |
18614839689 |
研究负责人电话:
Study leader's |
13998881093 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
ritatir@163.com |
研究负责人电子邮件: Study leader's E-mail: |
yuewen_m@sina.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
辽宁省沈阳市和平区南京北街155号中国医科大学附属第一医院 |
研究负责人通讯地址: |
辽宁省沈阳市和平区南京北街155号中国医科大学附属第一医院 |
|
Applicant address: |
the First Affiliated Hospital of China Medical University, No. 155 Nanjing North Street, Heping District, Shenyang City, Liaoning Province |
Study leader's address: |
the First Affiliated Hospital of China Medical University, No. 155 Nanjing North Street, Heping District, Shenyang City, Liaoning Province |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
中国医科大学附属第一医院 |
||
|
Applicant's institution: |
The First Affiliated Hospital of China Medical University |
||
|
研究负责人所在单位: |
中国医科大学附属第一医院 |
||
|
Affiliation of the Leader: |
The First Affiliated Hospital of China Medical University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
AF-SOP-07-1.1-01 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
中国医科大学附属第一医院医学科学研究伦理委员会 |
||
|
Name of the ethic committee: |
Medical Scientific Research Ethics Committee of The First Affiliated Hospital of China Medical University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2021-08-19 00:00:00 | ||
|
伦理委员会联系人: |
王印博 |
||
|
Contact Name of the ethic committee: |
Yinbo Wang |
||
|
伦理委员会联系地址: |
辽宁省沈阳市和平区南京北街155号中国医科大学附属第一医院1号楼11层 |
||
|
Contact Address of the ethic committee: |
11 / F, Building 1,The First Affiliated Hospital of China Medical University, 155 Nanjing North Street, Heping District, Shenyang City, Liaoning Province |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
024-83282837 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
中国医科大学附属第一医院 |
||||||||||||||||||||||
|
Primary sponsor: |
The First Affiliated Hospital of China Medical University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
辽宁省沈阳市和平区南京北街155号中国医科大学附属第一医院 |
||||||||||||||||||||||
|
Primary sponsor's address: |
155 Nanjing North Street, Heping District, Shenyang City, Liaoning Province |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
中国医科大学附属第一医院康复医学科学科建设经费 |
||||||||||||||||||||||
|
Source(s) of funding: |
Funds for the discipline construction of rehabilitation medicine in The First Affiliated Hospital of China Medical University |
||||||||||||||||||||||
|
研究疾病: |
腰椎间盘突出症 |
||||||||||||||||||||||
|
Target disease: |
lumbar disc herniation |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
治疗新技术临床试验 | ||||||||||||||||||||||
|
Study phase: |
New Treatment Measure Clinical Study |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
研究放散式体外冲击波治疗腰椎间盘突出症的临床疗效 |
||||||||||||||||||||||
|
Objectives of Study: |
To study the clinical efficacy of disseminated extracorporeal shock wave in the treatment of lumbar disc herniation. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
1.常规治疗组治疗方案 常规治疗组接受常规治疗,共14天,常规治疗方案参考《“腰椎间盘突出症的康复治疗”中国专家共识》[3]及《康复医学》[2]制定,每种治疗由相同的治疗师进行操作。 (1)健康教育:嘱患者佩戴腰部护具,起床时应向健侧侧身慢起,平日维持适量活动,避免旋转和弯腰动作,避免持重物及其他引起疼痛加重的活动,避免过量运动加重病情; (2)直流电离子导入疗法(电脑中频治疗仪,北京益康来科技有限公司生产,型号:YKL-B型):两电极分别置于腰部及症状较重的一侧下肢,分别导入COO—、Mg2+,电流密度0.05-0.1mA/cm2,每次20分钟,每日1次; (3)超短波治疗(立地式超短波治疗机,上海医疗器械高技术公司生产,规格:LDTCD-31):两电极分别置于腰部及腹部对置,无热量,每次7分钟,每日1次; (4)中频脉冲电疗法(电脑中频治疗仪,北京益康来科技有限公司生产,型号:YKL-B型):两电极分别置于腰椎两侧,电流20-30mA,每次20分钟,每日1次; (5)超声波疗法(超声治疗仪,英国EMS Physio Ltd.公司生产,型号:120):腰骶部椎体及双侧椎旁肌,1.5-2.0w/cm2,每次15分钟,每日1次。 2.冲击波组治疗方案 在常规治疗组所有治疗的基础上,增加放散式体外冲击波治疗(瑞士STORZ 公司生产,型号为MASTERPULS? MP100):在所有病变椎间盘的上下位椎骨及双侧椎旁肌区域涂抹耦合剂后,均匀移动地给予放散式体外冲击波治疗。冲击波参数为:经典探头,1.5-2.5bar,10Hz,2000点。冲击波治疗每周2次,共4次。 |
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
纳入标准: |
||||||||||||||||||||||
|
Inclusion criteria |
Inclusion criteria: |
||||||||||||||||||||||
|
排除标准: |
排除标准 |
||||||||||||||||||||||
|
Exclusion criteria: |
Exclusion criteria : |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2021-10-25 00:00:00至 To 2023-05-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2021-10-25 00:00:00 至 To 2023-05-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
随机数字表法 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Random number table method |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
单盲,指标测量人员对分组不知情 |
|
Blinding: |
Single blind.The evaluators do not know about the grouping. |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
- |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
- |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
使用病例记录表(CRF) |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
with Case Record Form(CRF) |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |